OnCore Login

Return to Trial Database

HCRN-LYM21-546

A phase II study of pembrolizumab and mogamulizumab in advanced-stage, relapsed/refractory cutaneous T-cell lymphomas

Status

Currently Enrolling

Cancer Type(s)

Lymphoma

Study Contact

(317) 921-2050
studies@hoosiercancer.org

Trial Locations

All sites in which the trial HCRN-LYM21-546 being conducted in.
University of Michigan Rogel Cancer Center
  • 7676 Interactive Way, Suite 120, Indianapolis, IN 46278